←
ESGCT2,402 posts
ESGCT avatar

ESGCT

@ESGCT

Official Twitter account of the European Society of Gene & Cell Therapy.

◷ Joined October 2011▧ 731 Photos and videos
ESGCT avatar
ESGCT@ESGCT·2 Oct 2024

Planned time: October 7th, 4 pm GMT (adjusted + 1/42 for EU timezones) Any questions? Write to us at ecrs@esgst.eu (4/4)

ESGCT avatar
ESGCT@ESGCT·2 Oct 2024

This one hour digital session will provide insight into best practice around communicating your work to diverse audiences as well as practical exercises, ora presentation skills and tips on how to make the most of your poster presentations and networking. (3/4)

ESGCT avatar
ESGCT@ESGCT·2 Oct 2024

ESGCT is teaming up with the EuroGCT to provide a pre-congress training on science communication and public speaking to help you get the most out of your conference poster presentation experience! (2/4)

ESGCT avatar
ESGCT@ESGCT·2 Oct 2024

Are you an ECR or first time Poster Presenter? Have you received the email "notification of poster presentation"? There is the registration link! (1/3)

Post attachment
ESGCT avatar
ESGCT@ESGCT·2 Sep 2024

𝐋𝐞𝐬𝐬 𝐭𝐡𝐚𝐧 𝐭𝐰𝐨 𝐦𝐨𝐧𝐭𝐡𝐬 𝐭𝐢𝐥𝐥 𝐨𝐮𝐫 𝐚𝐧𝐧𝐮𝐚𝐥 𝐦𝐞𝐞𝐭𝐢𝐧𝐠!  Looking forward to seeing you in Rome 🧬 Stay tuned for the early career researchers activities we’re preparing for you 🔜 (1/2)

0:11
ESGCT avatar
ESGCT@ESGCT·12 Jul 2024

2- Gene therapy in a novel large animal model of Stargardt disease, Ivana Trapani, TIGEM, Naples

ESGCT avatar
ESGCT@ESGCT·12 Jul 2024

1- Safe and effective liver-directed AAV-mediated homology-independent targeted integration in mouse models of inherited diseases, Federica Esposito, TIGEM, Naples

EURORDIS-Rare Diseases Europe avatar
⟳ ESGCT retweeted
EURORDIS-Rare Diseases Europe@eurordis·1 Jul 2024

🖥️ Do you have personal experience of situations impacted by digital health policy? 💭 Do you have ideas on how they could have been improved? 🫵 We want to hear from you! The application window for the EURORDIS DAG has been extended to 15 July. ➡️ go.eurordis.org/yfuFoK

EURORDIS-Rare Diseases Europe avatar
⟳ ESGCT retweeted
EURORDIS-Rare Diseases Europe@eurordis·24 Jun 2024

🚨There is just 1 week left to apply to our DAG! 🚨 The group offers EURORDIS expert guidance on all facets of digital health policies and procedures, drawing on members' personal experiences to shape our policies. ⏰ 30 June Learn more: go.eurordis.org/yfuFoK

Post attachment
SoniaGuedan avatar
⟳ ESGCT retweeted
SoniaGuedan@GuedanS·30 Apr 2024

💉 Overcoming T-cell inhibition via the PD-1/PD-L1 axis is a critical challenge in CAR-T cell therapy 📝 Our latest publication in @NatureComms unveils how CAR-antigen affinity could pivotally influence T-cell susceptibility to this axis ⬇️

Post attachment